These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 192891)

  • 1. The activity of polymyxins against Escherichia coli in an in-vitro model of the urinary bladder.
    Greenwood D; O'Grady F
    J Med Microbiol; 1977 May; 10(2):255-9. PubMed ID: 192891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of polymyxins against dense populations of Escherichia coli.
    Greenwood D
    J Gen Microbiol; 1975 Nov; 91(1):110-8. PubMed ID: 172601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum derivatives of polymyxin B and colistin.
    Witzke NM; Heding H
    J Antibiot (Tokyo); 1976 Dec; 29(12):1349-50. PubMed ID: 188797
    [No Abstract]   [Full Text] [Related]  

  • 4. SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS.
    BARNETT M; BUSHBY SR; WILKINSON S
    Br J Pharmacol Chemother; 1964 Dec; 23(3):552-74. PubMed ID: 14256814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The susceptibility of enteropathogenic and non-enteropathogenic porcine Escherichia coli strains to polymyxins and other antibiotics.
    Larsen JL; Søgaard H
    Nord Vet Med; 1981; 33(9-11):393-402. PubMed ID: 6276857
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium.
    Rogers MJ; Cohen J
    Infection; 1986; 14(2):79-81. PubMed ID: 3011678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the Individual Major Components of Polymyxin B and Colistin in Rats.
    Sivanesan S; Roberts K; Wang J; Chea SE; Thompson PE; Li J; Nation RL; Velkov T
    J Nat Prod; 2017 Jan; 80(1):225-229. PubMed ID: 28080060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice.
    Vingsbo Lundberg C; Vaara T; Frimodt-Møller N; Vaara M
    J Antimicrob Chemother; 2010 May; 65(5):981-5. PubMed ID: 20233777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the response of Escherichia coli to antibiotics in conditions prevailing in the infected urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1976 Jun; 57(3):303-9. PubMed ID: 182196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of polymyxin B and E (colistin) on blood coagulation, thrombocyte function, and fibrin structure (author's transl)].
    Klingemann HG; Egbring R; Kaffarnik H
    Arzneimittelforschung; 1980; 30(10):1719-21. PubMed ID: 6254544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron microscopic studies on mode of action of polymyxin.
    Koike M; Iida K; Matsuo T
    J Bacteriol; 1969 Jan; 97(1):448-52. PubMed ID: 4303542
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the mechanism of action of colistin. IV. Activation of "latent" ribonuclease in Escherichia coli by colistin.
    Nakajima K; Kawamata J
    Biken J; 1966 Jun; 9(2):115-23. PubMed ID: 4288005
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
    Jones RN; Anderegg TR; Swenson JM;
    J Clin Microbiol; 2005 Feb; 43(2):925-7. PubMed ID: 15695708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel derivatives of polymyxins.
    Vaara M
    J Antimicrob Chemother; 2013 Jun; 68(6):1213-9. PubMed ID: 23412346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of antimicrobial agents. I. The in vitro sensitivity of 100 strains of Pseudomonas aeruginosa to polymyxin B, colistin, carbenicillin, gentamicin and doxycycline and to various combinations of these antibiotics.
    Kuipers JS
    Arch Chir Neerl; 1975; 27(4):257-70. PubMed ID: 174496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance in vitro of Psudomonas aeruginosa to gentamicin compared with colistin and polymyxin B].
    Bergan T
    Nord Med; 1969 Jan; 81(3):73-5. PubMed ID: 4304204
    [No Abstract]   [Full Text] [Related]  

  • 17. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
    Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
    J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
    van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity to antibiotics of Escherichia coli strains isolated from children admitted to the "Sf. Ioan" clinical emergency hospital for children in Galaţi during 2005-2006].
    Florea C
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):37-44. PubMed ID: 18441957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.